Sense Biodetection: Sense Announces New Executive Appointment as Company Prepares to Launch its Veros COVID-19 Test
Nancy Lelicoff Joins as Executive Vice President of Regulatory, Quality Assurance and Clinical Affairs Global molecular diagnostics innovator,Sense Biodetection (Sense), today announced the appointment
Source: finanznachrichten.de